Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.
Document Type
Article
Publication Date
12-30-2021
Publication Title
J Cancer Prev
Keywords
oregon; portland; chiles; Chemoprevention; Clinical trials; Immunomodulatory agents; Immunoprevention; Preventive vaccines
Abstract
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the "Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents" as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.
Clinical Institute
Cancer
Department
Oncology
Department
Earle A. Chiles Research Institute
Department
Pharmacy
Recommended Citation
Mohammed, Altaf; Dashwood, Roderick H; Dickinson, Sally; Disis, Mary L; Jaffee, Elizabeth M; Johnson, Bryon D; Khleif, Samir N; Pollak, Michael N; Schlom, Jeffrey; Shoemaker, Robert H; Stanton, Sasha; Wondrak, Georg T; You, Ming; Zhu, Hao; and Miller, Mark Steven, "Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report." (2021). Articles, Abstracts, and Reports. 5782.
https://digitalcommons.providence.org/publications/5782
